ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
about
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingGeographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisHealth personnel retention strategies in a peri-urban community: an exploratory study on Epworth, Zimbabwe.ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method studyThe ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimenWhen could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank.The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Long-acting slow effective release antiretroviral therapy.Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?A Framework for Health Communication Across the HIV Treatment Continuum.How can we achieve universal access to low-cost treatment for HIV?Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals.The impact of a therapeutic exercise intervention on depression and body self-image in HIV-positive women in sub-Saharan Africa
P2860
Q28271593-B16D6F5F-D3BD-42AD-9D39-B01787027104Q28545866-F59A9ACF-91FB-47B3-A588-F43FCD05E121Q30384960-5B418BDB-B960-439F-B999-C7D746A337F7Q30831066-E1F149AC-A8EA-4453-85C7-EE59755878A7Q33765178-BFFC4C80-FB34-4F7A-9C49-48DE906CF678Q33765196-A19FB179-F62A-426B-86CF-715EC46D53A7Q35850530-ADAB5A62-CE59-445B-890D-AD33FB173050Q36262152-C1849D3F-66A7-455D-A33B-9E76A22DD227Q36541070-F4312DA6-2CE6-4AD8-8CF0-6DEE17B8DE82Q37488499-CE57B860-E92D-4A97-958E-CBF94C258ACFQ42380889-A7ED17C7-36CA-4D5C-B3F5-67B4A04872DAQ42851887-6A8C00A0-F726-47D8-AEA4-2836958AD235Q54253541-A4E7A436-8BB2-4469-8544-E5B3BA4A51FFQ56933734-B25523D6-6811-4124-9EB4-2D76087D94A1
P2860
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@en
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@nl
type
label
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@en
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@nl
prefLabel
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@en
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@nl
P2860
P356
P1476
ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.
@en
P2093
James D Shelton
Matthew Barnhart
P2860
P356
10.9745/GHSP-D-14-00243
P577
2015-01-27T00:00:00Z